Early Treatment of Acute Myocardial Infarction with Melatonin: Effects on MMP-9 and Adverse Cardiac Events.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1909, doi. 10.3390/jcm11071909
- By:
- Publication type:
- Article
Works by Simko, Fedor
Results: 52
1
2
Pharmacological stimulation of the parasympathetic system – a promising means of cardioprotection in heart failure.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
3
Melatonin as a rational alternative in the conservative treatment of resistant hypertension.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
4
Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 733, doi. 10.3390/biomedicines12040733
- By:
- Publication type:
- Article
5
Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081844
- By:
- Publication type:
- Article
6
The effects of body weight loss and gain on arterial hypertension control: an observational prospective study.
- Published in:
- European Journal of Medical Research, 2017, v. 22, p. 1, doi. 10.1186/s40001-017-0286-5
- By:
- Publication type:
- Article
7
Captopril increased mitochondrial coenzyme Q... level, improved respiratory chain function and...
- Published in:
- Biofactors, 1999, v. 10, n. 1, p. 61
- By:
- Publication type:
- Article
8
MEDICAL RESEARCHERS IN THE SLOVAK REPUBLIC SEEK COOPERATION WITH CANADIANS.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1996, v. 154, n. 3, p. 301
- By:
- Publication type:
- Article
9
Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 1, p. 88, doi. 10.3390/life14010088
- By:
- Publication type:
- Article
10
Melatonin as a Potential Approach to Anxiety Treatment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 16187, doi. 10.3390/ijms232416187
- By:
- Publication type:
- Article
11
The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4762, doi. 10.3390/ijms22094762
- By:
- Publication type:
- Article
12
Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 2069, doi. 10.3390/ijms22042069
- By:
- Publication type:
- Article
13
Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8038, doi. 10.3390/ijms21218038
- By:
- Publication type:
- Article
14
Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 3017, doi. 10.3390/ijms19103017
- By:
- Publication type:
- Article
15
Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1612, doi. 10.3390/ijms18081612
- By:
- Publication type:
- Article
16
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 7, p. 1098, doi. 10.3390/ijms17071098
- By:
- Publication type:
- Article
17
Peripheral and Central Effects of Melatonin on Blood Pressure Regulation.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 10, p. 17920, doi. 10.3390/ijms151017920
- By:
- Publication type:
- Article
18
The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760.
- Published in:
- Biological Research, 2023, v. 56, n. 1, p. 1, doi. 10.1186/s40659-023-00466-x
- By:
- Publication type:
- Article
19
Ivabradine reversed nondipping heart rate in rats with l‐NAME‐induced hypertension.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 6, p. 607, doi. 10.1111/1440-1681.13075
- By:
- Publication type:
- Article
20
Chronotherapy as a potential approach to hypertensive patients with elevated heart rate?
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 8, p. 1861, doi. 10.1111/bcp.14020
- By:
- Publication type:
- Article
21
Cardiac troponins-Translational biomarkers in cardiology: Theory and practice of cardiac troponin high-sensitivity assays.
- Published in:
- Biofactors, 2016, v. 42, n. 2, p. 133, doi. 10.1002/biof.1261
- By:
- Publication type:
- Article
22
Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin.
- Published in:
- Mediators of Inflammation, 2014, v. 2014, p. 1, doi. 10.1155/2014/703175
- By:
- Publication type:
- Article
23
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
- Published in:
- Clinical Science, 2021, v. 135, n. 8, p. 1009, doi. 10.1042/CS20210182
- By:
- Publication type:
- Article
24
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2022.842512
- By:
- Publication type:
- Article
25
Ivabradine curbs isoproterenol-induced kidney fibrosis.
- Published in:
- General Physiology & Biophysics, 2023, v. 42, n. 2, p. 209, doi. 10.4149/gpb_2022057
- By:
- Publication type:
- Article
26
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
- Published in:
- General Physiology & Biophysics, 2020, v. 39, n. 3, p. 203, doi. 10.4149/gpb_2020019
- By:
- Publication type:
- Article
27
Lisinopril reverses behavioural alterations in spontaneously hypertensive rats.
- Published in:
- General Physiology & Biophysics, 2019, v. 38, n. 3, p. 265, doi. 10.4149/gpb_2019011
- By:
- Publication type:
- Article
28
Gene therapy for hypertension.
- Published in:
- Expert Opinion on Biological Therapy, 2017, v. 17, n. 11, p. 1345, doi. 10.1080/14712598.2017.1364726
- By:
- Publication type:
- Article
29
Is NO the King? Pathophysiological Benefit with Uncertain Clinical Impact.
- Published in:
- Physiological Research, 2007, v. 56, p. S1, doi. 10.33549/physiolres.931391
- By:
- Publication type:
- Article
30
17β-Estradiol treatment reversed left ventricular dysfunction in castrated male rats: an echocardiographic study.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2018, v. 96, n. 8, p. 850, doi. 10.1139/cjpp-2017-0596
- By:
- Publication type:
- Article
31
Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.
- Published in:
- Hypertension Research, 2009, v. 32, n. 4, p. 242, doi. 10.1038/hr.2009.12
- By:
- Publication type:
- Article
32
Regression of L-NAME-Induced Hypertension: The Role of Nitric Oxide and Endothelium-Derived Constricting Factor.
- Published in:
- Hypertension Research, 2008, v. 31, n. 4, p. 793, doi. 10.1291/hypres.31.793
- By:
- Publication type:
- Article
33
Melatonin use for SARS‐CoV‐2 infection: Time to diversify the treatment portfolio.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 7, p. 2928, doi. 10.1002/jmv.27740
- By:
- Publication type:
- Article
34
Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.978337
- By:
- Publication type:
- Article
35
New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
- Published in:
- Current Hypertension Reports, 2015, v. 17, n. 6, p. 1, doi. 10.1007/s11906-015-0557-x
- By:
- Publication type:
- Article
36
Cardiovascular therapeutics: A new potential for anxiety treatment?
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1202, doi. 10.1002/med.21875
- By:
- Publication type:
- Article
37
Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury.
- Published in:
- Fundamental & Clinical Pharmacology, 2021, v. 35, n. 4, p. 744, doi. 10.1111/fcp.12620
- By:
- Publication type:
- Article
38
Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review.
- Published in:
- Journal of Pineal Research, 2016, v. 61, n. 2, p. 127, doi. 10.1111/jpi.12348
- By:
- Publication type:
- Article
39
Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure.
- Published in:
- Journal of Pineal Research, 2014, v. 57, n. 2, p. 177, doi. 10.1111/jpi.12154
- By:
- Publication type:
- Article
40
Melatonin interactions with blood pressure and vascular function duringl-NAME-induced hypertension.
- Published in:
- Journal of Pineal Research, 2010, v. 48, n. 2, p. 102, doi. 10.1111/j.1600-079X.2009.00732.x
- By:
- Publication type:
- Article
41
Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment.
- Published in:
- Journal of Pineal Research, 2009, v. 47, n. 2, p. 127, doi. 10.1111/j.1600-079X.2009.00697.x
- By:
- Publication type:
- Article
42
Chronotherapy beyond blood pressure reduction?
- Published in:
- 2008
- By:
- Publication type:
- Letter
43
Melatonin as a potential antihypertensive treatment.
- Published in:
- Journal of Pineal Research, 2007, v. 42, n. 4, p. 319, doi. 10.1111/j.1600-079X.2007.00436.x
- By:
- Publication type:
- Article
44
Melatonin as a putative protection against myocardial injury in COVID-19 infection.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
45
What prevents cardioprotective drugs from reaching the market?
- Published in:
- Expert Review of Clinical Pharmacology, 2018, v. 11, n. 5, p. 463, doi. 10.1080/17512433.2018.1447924
- By:
- Publication type:
- Article
46
Melatonin stabilizes atherosclerotic plaques: an association that should be clinically exploited.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1487971
- By:
- Publication type:
- Article
47
EFFECT OF CAPTOPRIL IN L-NAME-INDUCED HYPERTENSION ON THE RAT MYOCARDIUM, AORTA, BRAIN AND KIDNEY.
- Published in:
- Experimental Physiology, 1999, v. 84, n. 6, p. 1095
- By:
- Publication type:
- Article
48
Chronobiology of blood pressure: emerging implications of melatonin.
- Published in:
- European Journal of Clinical Investigation, 2012, v. 42, n. 11, p. 1252, doi. 10.1111/j.1365-2362.2012.02705.x
- By:
- Publication type:
- Article
49
Chronotherapy of cardiovascular pathologies: a hopeful strategy.
- Published in:
- 2022
- By:
- Publication type:
- Letter
50
Chronotherapy of cardiovascular pathologies: a hopeful strategy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223221092372
- By:
- Publication type:
- Article